APO Research
Talk to an analyst

APO RESEARCH · REPORT

CGT Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global CGT Drugs Industry Growth and Trends Forecast to 2032

29 December 2025108 pages

Choose your research edition.

Industry ResearchCGT Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal CGT Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal CGT Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CGT Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal CGT Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global CGT Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for CGT Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for CGT Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for CGT Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of CGT Drugs include Bluebird Bio, Celgene Corporation, Juno Therapeutics, Kite Pharma, Orchard Therapeutics, Spark Therapeutics, Amgen, Fosun Kite Biotechnology and GSK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global CGT Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The CGT Drugs market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CGT Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CGT Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global CGT Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

CGT Drugs Market by Company

Bluebird Bio

Celgene Corporation

Juno Therapeutics

Kite Pharma

Orchard Therapeutics

Spark Therapeutics

Amgen

Fosun Kite Biotechnology

GSK

Novartis

SiBiono

Sunway Biotech

Janssen Biotech

Sequoia

CGT Drugs Segment by Type

CAR-T Therapy

Viral Vector Therapy

Stem Cell Therapy

Oncolytic Virus Therapy

CGT Drugs Segment by Application

Tumor Disease

Eye Disease

Rare Disease

Others

CGT Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CGT Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CGT Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CGT Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of CGT Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of CGT Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CAR-T Therapy Table 2. Major Company of Viral Vector Therapy Table 3. Major Company of Stem Cell Therapy Table 4. Major Company of Oncolytic Virus Therapy Table 5. Global CGT Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global CGT Drugs Sales by Type (2021-2026) & (Tons) Table 7. Global CGT Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global CGT Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global CGT Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global CGT Drugs Price by Type (2021-2026) & (US$/Ton) Table 11. Global CGT Drugs Sales by Type (2027-2032) & (Tons) Table 12. Global CGT Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global CGT Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global CGT Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global CGT Drugs Price by Type (2027-2032) & (US$/Ton) Table 16. North America CGT Drugs Sales by Type (2021-2026) & (Tons) Table 17. North America CGT Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe CGT Drugs Sales by Type (2021-2026) & (Tons) Table 19. Europe CGT Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific CGT Drugs Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific CGT Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America CGT Drugs Sales by Type (2021-2026) & (Tons) Table 23. Latin America CGT Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa CGT Drugs Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa CGT Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. CGT Drugs Industry Trends Table 27. CGT Drugs Industry Drivers Table 28. CGT Drugs Industry Opportunities and Challenges Table 29. CGT Drugs Industry Restraints Table 30. Global CGT Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global CGT Drugs Revenue Market Share by Company (2021-2026) Table 32. Global CGT Drugs Sales by Company (2021-2026) & (Tons) Table 33. Global CGT Drugs Sales Share by Company (2021-2026) Table 34. Global CGT Drugs Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global CGT Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global CGT Drugs Major Company Production Sites and Headquarters Table 37. Global CGT Drugs Company, Product Type & Application Table 38. Global CGT Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global CGT Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global CGT Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global CGT Drugs Sales by Region (2021-2026) & (Tons) Table 43. Global CGT Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global CGT Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global CGT Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global CGT Drugs Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global CGT Drugs Sales by Region (2027-2032) & (Tons) Table 48. Global CGT Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global CGT Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global CGT Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global CGT Drugs Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global CGT Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global CGT Drugs Sales by Application (2021-2026) & (Tons) Table 54. Global CGT Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global CGT Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global CGT Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global CGT Drugs Price by Application (2021-2026) & (US$/Ton) Table 58. Global CGT Drugs Sales by Application (2027-2032) & (Tons) Table 59. Global CGT Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global CGT Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global CGT Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global CGT Drugs Price by Application (2027-2032) & (US$/Ton) Table 63. North America CGT Drugs Sales by Application (2021-2026) & (Tons) Table 64. North America CGT Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe CGT Drugs Sales by Application (2021-2026) & (Tons) Table 66. Europe CGT Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific CGT Drugs Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific CGT Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America CGT Drugs Sales by Application (2021-2026) & (Tons) Table 70. Latin America CGT Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa CGT Drugs Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa CGT Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Bluebird Bio Company Information Table 74. Bluebird Bio Business Overview Table 75. Bluebird Bio CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Bluebird Bio CGT Drugs Product Portfolio Table 77. Bluebird Bio Recent Development Table 78. Celgene Corporation Company Information Table 79. Celgene Corporation Business Overview Table 80. Celgene Corporation CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Celgene Corporation CGT Drugs Product Portfolio Table 82. Celgene Corporation Recent Development Table 83. Juno Therapeutics Company Information Table 84. Juno Therapeutics Business Overview Table 85. Juno Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Juno Therapeutics CGT Drugs Product Portfolio Table 87. Juno Therapeutics Recent Development Table 88. Kite Pharma Company Information Table 89. Kite Pharma Business Overview Table 90. Kite Pharma CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Kite Pharma CGT Drugs Product Portfolio Table 92. Kite Pharma Recent Development Table 93. Orchard Therapeutics Company Information Table 94. Orchard Therapeutics Business Overview Table 95. Orchard Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Orchard Therapeutics CGT Drugs Product Portfolio Table 97. Orchard Therapeutics Recent Development Table 98. Spark Therapeutics Company Information Table 99. Spark Therapeutics Business Overview Table 100. Spark Therapeutics CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Spark Therapeutics CGT Drugs Product Portfolio Table 102. Spark Therapeutics Recent Development Table 103. Amgen Company Information Table 104. Amgen Business Overview Table 105. Amgen CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Amgen CGT Drugs Product Portfolio Table 107. Amgen Recent Development Table 108. Fosun Kite Biotechnology Company Information Table 109. Fosun Kite Biotechnology Business Overview Table 110. Fosun Kite Biotechnology CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Fosun Kite Biotechnology CGT Drugs Product Portfolio Table 112. Fosun Kite Biotechnology Recent Development Table 113. GSK Company Information Table 114. GSK Business Overview Table 115. GSK CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. GSK CGT Drugs Product Portfolio Table 117. GSK Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Novartis CGT Drugs Product Portfolio Table 122. Novartis Recent Development Table 123. SiBiono Company Information Table 124. SiBiono Business Overview Table 125. SiBiono CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. SiBiono CGT Drugs Product Portfolio Table 127. SiBiono Recent Development Table 128. Sunway Biotech Company Information Table 129. Sunway Biotech Business Overview Table 130. Sunway Biotech CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Sunway Biotech CGT Drugs Product Portfolio Table 132. Sunway Biotech Recent Development Table 133. Janssen Biotech Company Information Table 134. Janssen Biotech Business Overview Table 135. Janssen Biotech CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Janssen Biotech CGT Drugs Product Portfolio Table 137. Janssen Biotech Recent Development Table 138. Sequoia Company Information Table 139. Sequoia Business Overview Table 140. Sequoia CGT Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Sequoia CGT Drugs Product Portfolio Table 142. Sequoia Recent Development Table 143. North America CGT Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 144. North America CGT Drugs Sales by Country (2021-2026) & (Tons) Table 145. North America CGT Drugs Sales Market Share by Country (2021-2026) Table 146. North America CGT Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 147. North America CGT Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. North America CGT Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America CGT Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. North America CGT Drugs Market Share by Country (2021-2026) Table 151. North America CGT Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America CGT Drugs Market Share Forecast by Country (2027-2032) Table 153. Europe CGT Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 154. Europe CGT Drugs Sales by Country (2021-2026) & (Tons) Table 155. Europe CGT Drugs Sales Market Share by Country (2021-2026) Table 156. Europe CGT Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 157. Europe CGT Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Europe CGT Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe CGT Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe CGT Drugs Market Share by Country (2021-2026) Table 161. Europe CGT Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe CGT Drugs Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific CGT Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific CGT Drugs Sales by Country (2021-2026) & (Tons) Table 165. Asia-Pacific CGT Drugs Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific CGT Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 167. Asia-Pacific CGT Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific CGT Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific CGT Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific CGT Drugs Market Share by Country (2021-2026) Table 171. Asia-Pacific CGT Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific CGT Drugs Market Share Forecast by Country (2027-2032) Table 173. Latin America CGT Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 174. Latin America CGT Drugs Sales by Country (2021-2026) & (Tons) Table 175. Latin America CGT Drugs Sales Market Share by Country (2021-2026) Table 176. Latin America CGT Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 177. Latin America CGT Drugs Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America CGT Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America CGT Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America CGT Drugs Market Share by Country (2021-2026) Table 181. Latin America CGT Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America CGT Drugs Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa CGT Drugs Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa CGT Drugs Sales by Country (2021-2026) & (Tons) Table 185. Middle East and Africa CGT Drugs Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa CGT Drugs Sales Forecast by Country (2027-2032) & (Tons) Table 187. Middle East and Africa CGT Drugs Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa CGT Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa CGT Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa CGT Drugs Market Share by Country (2021-2026) Table 191. Middle East and Africa CGT Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa CGT Drugs Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. CGT Drugs Distributors List Table 196. CGT Drugs Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. CGT Drugs Image Figure 2. Global CGT Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CGT Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global CGT Drugs Sales (2021-2032) & (Tons) Figure 5. CAR-T Therapy Image Figure 6. Global CAR-T Therapy Sales YoY Growth (2021-2032) & (Tons) Figure 7. Viral Vector Therapy Image Figure 8. Global Viral Vector Therapy Sales YoY Growth (2021-2032) & (Tons) Figure 9. Stem Cell Therapy Image Figure 10. Global Stem Cell Therapy Sales YoY Growth (2021-2032) & (Tons) Figure 11. Oncolytic Virus Therapy Image Figure 12. Global Oncolytic Virus Therapy Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global CGT Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global CGT Drugs Market Share by Type 2025 VS 2032 Figure 15. North America CGT Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America CGT Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe CGT Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe CGT Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific CGT Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific CGT Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America CGT Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America CGT Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa CGT Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa CGT Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 CGT Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Tumor Disease Image Figure 28. Global Tumor Disease Sales YoY Growth (2021-2032) & (Tons) Figure 29. Eye Disease Image Figure 30. Global Eye Disease Sales YoY Growth (2021-2032) & (Tons) Figure 31. Rare Disease Image Figure 32. Global Rare Disease Sales YoY Growth (2021-2032) & (Tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 35. Global CGT Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global CGT Drugs Market Share by Application 2025 VS 2032 Figure 37. North America CGT Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America CGT Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe CGT Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe CGT Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific CGT Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific CGT Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America CGT Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America CGT Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa CGT Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa CGT Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America CGT Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. North America CGT Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America CGT Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America CGT Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe CGT Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Europe CGT Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe CGT Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe CGT Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific CGT Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Asia-Pacific CGT Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific CGT Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific CGT Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America CGT Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Latin America CGT Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America CGT Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America CGT Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa CGT Drugs Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 64. Middle East and Africa CGT Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa CGT Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa CGT Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. CGT Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. CGT Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • CAR-T Therapy
  • Viral Vector Therapy
  • Stem Cell Therapy
  • Oncolytic Virus Therapy
Applications
  • Tumor Disease
  • Eye Disease
  • Rare Disease
  • Others
Companies covered
  • Bluebird Bio
  • Celgene Corporation
  • Juno Therapeutics
  • Kite Pharma
  • Orchard Therapeutics
  • Spark Therapeutics
  • Amgen
  • Fosun Kite Biotechnology
  • GSK
  • Novartis
  • SiBiono
  • Sunway Biotech
  • Janssen Biotech
  • Sequoia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global CGT Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global CGT Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 CGT Drugs Market by Type
  6. 1.3.1 CAR-T Therapy
  7. 1.3.2 Viral Vector Therapy
  8. 1.3.3 Stem Cell Therapy
  9. 1.3.4 Oncolytic Virus Therapy
  10. 1.4 Global CGT Drugs Market Size by Type
  11. 1.4.1 Global CGT Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global CGT Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global CGT Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America CGT Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe CGT Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific CGT Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America CGT Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa CGT Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 CGT Drugs Industry Trends
  2. 2.2 CGT Drugs Industry Drivers
  3. 2.3 CGT Drugs Industry Opportunities and Challenges
  4. 2.4 CGT Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by CGT Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by CGT Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by CGT Drugs Price (2021-2026)
  4. 3.4 Global CGT Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global CGT Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global CGT Drugs Company, Product Type & Application
  7. 3.7 Global CGT Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global CGT Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 CGT Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 CGT Drugs Tier 1, Tier 2, and Tier 3
4 CGT Drugs Regional Status and Outlook
  1. 4.1 Global CGT Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global CGT Drugs Historic Market Size by Region
  3. 4.2.1 Global CGT Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global CGT Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global CGT Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global CGT Drugs Forecasted Market Size by Region
  7. 4.3.1 Global CGT Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global CGT Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global CGT Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 CGT Drugs by Application
  1. 5.1 CGT Drugs Market by Application
  2. 5.1.1 Tumor Disease
  3. 5.1.2 Eye Disease
  4. 5.1.3 Rare Disease
  5. 5.1.4 Others
  6. 5.2 Global CGT Drugs Market Size by Application
  7. 5.2.1 Global CGT Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global CGT Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global CGT Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America CGT Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe CGT Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific CGT Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America CGT Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa CGT Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bluebird Bio
  2. 6.1.1 Bluebird Bio Company Information
  3. 6.1.2 Bluebird Bio Business Overview
  4. 6.1.3 Bluebird Bio CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bluebird Bio CGT Drugs Product Portfolio
  6. 6.1.5 Bluebird Bio Recent Developments
  7. 6.2 Celgene Corporation
  8. 6.2.1 Celgene Corporation Company Information
  9. 6.2.2 Celgene Corporation Business Overview
  10. 6.2.3 Celgene Corporation CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Celgene Corporation CGT Drugs Product Portfolio
  12. 6.2.5 Celgene Corporation Recent Developments
  13. 6.3 Juno Therapeutics
  14. 6.3.1 Juno Therapeutics Company Information
  15. 6.3.2 Juno Therapeutics Business Overview
  16. 6.3.3 Juno Therapeutics CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Juno Therapeutics CGT Drugs Product Portfolio
  18. 6.3.5 Juno Therapeutics Recent Developments
  19. 6.4 Kite Pharma
  20. 6.4.1 Kite Pharma Company Information
  21. 6.4.2 Kite Pharma Business Overview
  22. 6.4.3 Kite Pharma CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kite Pharma CGT Drugs Product Portfolio
  24. 6.4.5 Kite Pharma Recent Developments
  25. 6.5 Orchard Therapeutics
  26. 6.5.1 Orchard Therapeutics Company Information
  27. 6.5.2 Orchard Therapeutics Business Overview
  28. 6.5.3 Orchard Therapeutics CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Orchard Therapeutics CGT Drugs Product Portfolio
  30. 6.5.5 Orchard Therapeutics Recent Developments
  31. 6.6 Spark Therapeutics
  32. 6.6.1 Spark Therapeutics Company Information
  33. 6.6.2 Spark Therapeutics Business Overview
  34. 6.6.3 Spark Therapeutics CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Spark Therapeutics CGT Drugs Product Portfolio
  36. 6.6.5 Spark Therapeutics Recent Developments
  37. 6.7 Amgen
  38. 6.7.1 Amgen Company Information
  39. 6.7.2 Amgen Business Overview
  40. 6.7.3 Amgen CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Amgen CGT Drugs Product Portfolio
  42. 6.7.5 Amgen Recent Developments
  43. 6.8 Fosun Kite Biotechnology
  44. 6.8.1 Fosun Kite Biotechnology Company Information
  45. 6.8.2 Fosun Kite Biotechnology Business Overview
  46. 6.8.3 Fosun Kite Biotechnology CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fosun Kite Biotechnology CGT Drugs Product Portfolio
  48. 6.8.5 Fosun Kite Biotechnology Recent Developments
  49. 6.9 GSK
  50. 6.9.1 GSK Company Information
  51. 6.9.2 GSK Business Overview
  52. 6.9.3 GSK CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GSK CGT Drugs Product Portfolio
  54. 6.9.5 GSK Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis CGT Drugs Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 SiBiono
  62. 6.11.1 SiBiono Company Information
  63. 6.11.2 SiBiono Business Overview
  64. 6.11.3 SiBiono CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SiBiono CGT Drugs Product Portfolio
  66. 6.11.5 SiBiono Recent Developments
  67. 6.12 Sunway Biotech
  68. 6.12.1 Sunway Biotech Company Information
  69. 6.12.2 Sunway Biotech Business Overview
  70. 6.12.3 Sunway Biotech CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sunway Biotech CGT Drugs Product Portfolio
  72. 6.12.5 Sunway Biotech Recent Developments
  73. 6.13 Janssen Biotech
  74. 6.13.1 Janssen Biotech Company Information
  75. 6.13.2 Janssen Biotech Business Overview
  76. 6.13.3 Janssen Biotech CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Janssen Biotech CGT Drugs Product Portfolio
  78. 6.13.5 Janssen Biotech Recent Developments
  79. 6.14 Sequoia
  80. 6.14.1 Sequoia Company Information
  81. 6.14.2 Sequoia Business Overview
  82. 6.14.3 Sequoia CGT Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sequoia CGT Drugs Product Portfolio
  84. 6.14.5 Sequoia Recent Developments
7 North America by Country
  1. 7.1 North America CGT Drugs Sales by Country
  2. 7.1.1 North America CGT Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America CGT Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America CGT Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America CGT Drugs Market Size by Country
  6. 7.2.1 North America CGT Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America CGT Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America CGT Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe CGT Drugs Sales by Country
  2. 8.1.1 Europe CGT Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe CGT Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe CGT Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe CGT Drugs Market Size by Country
  6. 8.2.1 Europe CGT Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe CGT Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe CGT Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific CGT Drugs Sales by Country
  2. 9.1.1 Asia-Pacific CGT Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific CGT Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific CGT Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific CGT Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific CGT Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific CGT Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific CGT Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America CGT Drugs Sales by Country
  2. 10.1.1 South America CGT Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America CGT Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America CGT Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America CGT Drugs Market Size by Country
  6. 10.2.1 South America CGT Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America CGT Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America CGT Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa CGT Drugs Sales by Country
  2. 11.1.1 Middle East and Africa CGT Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa CGT Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa CGT Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa CGT Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa CGT Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa CGT Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa CGT Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 CGT Drugs Value Chain Analysis
  2. 12.1.1 CGT Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 CGT Drugs Production Mode & Process
  7. 12.2 CGT Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 CGT Drugs Distributors
  10. 12.2.3 CGT Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst